PubMed Buckley, S.T., Bkdal, T.A., Vegge, A., Maarbjerg, S.J., Pyke, C., Ahnfelt-Rnne, J., Madsen, K.G., Schele, S.G., Alanentalo, T., Kirk, R.K., Pedersen, B.L., Skyggebjerg, R.B., Benie, A.J., Strauss, H.M., Wahlund, P.O., Bjerregaard, S., Farkas, E., Fekete, C., Sndergaard, F.L., Borregaard, J., Hartoft-Nielsen, M.L., & Knudsen, L.B
Association of activated transcription factor NF-kappaB with chemo-radiotherapy resistance and poor outcome in esophageal adenocarcinoma
NAD+ might cause mild discomfort during treatment - things like flushing, nausea, or chest tightness
This is where I will often turn to BPC-157 peptide therapy , especially BPC-157
SelfEvolve L-Glutathione Antioxidant & Cellular Support